Join
Live feed
·
INSIDERFilingvia Quantisnow
Esperion Therapeutics Inc. logo

Director Thompson John Craig returned 79,873 shares to the company, closing all direct ownership in the company (SEC Form 4) (tax liability)

ByQuantisnow·Wall Street's wire, on your screen.
ESPR· Esperion Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ESPR (Esperion Therapeutics Inc.) and more on Quantisnow.